Harrow Inc (HROW)
43.88
+1.44
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
43.58
-0.30
(-0.68%)
After-Hours: 20:00
Harrow Enterprise Value: 1.676B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.676B |
| November 20, 2024 | 1.625B |
| November 19, 2024 | 1.527B |
| November 18, 2024 | 1.465B |
| November 15, 2024 | 1.502B |
| November 14, 2024 | 1.640B |
| November 13, 2024 | 1.958B |
| November 12, 2024 | 1.891B |
| November 11, 2024 | 1.966B |
| November 08, 2024 | 1.983B |
| November 07, 2024 | 1.890B |
| November 06, 2024 | 1.831B |
| November 05, 2024 | 1.744B |
| November 04, 2024 | 1.745B |
| November 01, 2024 | 1.738B |
| October 31, 2024 | 1.718B |
| October 30, 2024 | 1.695B |
| October 29, 2024 | 1.771B |
| October 28, 2024 | 1.794B |
| October 25, 2024 | 1.915B |
| October 24, 2024 | 2.002B |
| October 23, 2024 | 2.044B |
| October 22, 2024 | 2.142B |
| October 21, 2024 | 2.122B |
| October 18, 2024 | 2.160B |
| Date | Value |
|---|---|
| October 17, 2024 | 2.122B |
| October 16, 2024 | 2.065B |
| October 15, 2024 | 2.018B |
| October 14, 2024 | 1.925B |
| October 11, 2024 | 1.919B |
| October 10, 2024 | 1.882B |
| October 09, 2024 | 1.929B |
| October 08, 2024 | 1.929B |
| October 07, 2024 | 1.916B |
| October 04, 2024 | 1.907B |
| October 03, 2024 | 1.885B |
| October 02, 2024 | 1.747B |
| October 01, 2024 | 1.696B |
| September 30, 2024 | 1.714B |
| September 27, 2024 | 1.677B |
| September 26, 2024 | 1.683B |
| September 25, 2024 | 1.691B |
| September 24, 2024 | 1.743B |
| September 23, 2024 | 1.691B |
| September 20, 2024 | 1.711B |
| September 19, 2024 | 1.763B |
| September 18, 2024 | 1.722B |
| September 17, 2024 | 1.660B |
| September 16, 2024 | 1.674B |
| September 13, 2024 | 1.715B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
73.09M
Minimum
Mar 23 2020
2.160B
Maximum
Oct 18 2024
432.63M
Average
251.23M
Median
Aug 11 2022
Enterprise Value Benchmarks
| Calidi Biotherapeutics Inc | 44.16M |
| NovaBay Pharmaceuticals Inc | 2.745M |
| Palatin Technologies Inc | 15.49M |
| iBio Inc | 9.932M |
| Theriva Biologics Inc | -12.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.22M |
| Revenue (Quarterly) | 49.26M |
| Total Expenses (Quarterly) | 47.94M |
| EPS Diluted (Quarterly) | -0.12 |
| Gross Profit Margin (Quarterly) | 75.60% |
| Profit Margin (Quarterly) | -8.57% |
| Earnings Yield | -2.16% |
| Normalized Earnings Yield | -1.990 |